News
At Texas A&M AgriLife Research, a new branch of brain science is blooming at the molecular scale—with nanoflowers.
1mon
AZoLifeSciences on MSNNew Insights into the Molecular Fight or Flight ResetBeing cut off in traffic, giving a presentation or missing a meal can all trigger a suite of physiological changes that allows the body to react swiftly to stress or starvation.
Being cut off in traffic, giving a presentation or missing a meal can all trigger a suite of physiological changes that allow the body to react swiftly to stress or starvation. Critical to this "fight ...
Juri Biosciences is offering EpimAb up to $210 million biobucks for licensing rights to a T-cell engager designed to treat metastatic prostate cancer.
AGC Biologics supports the development of multiple Treg cell therapy drug candidates targeting severe immune disorders for Quell Therapeutics.
Phase 1 and 2 trials of immunomodulatory drugs test ways to quell cytotoxic T cells beckoned to the AD brain. Low dose IL-2 and a nasal anti-CD3 antibody aim to expand T regulatory cells. In one ...
A new chimeric antigen receptor (CAR) T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types ...
Egle Therapeutics unveils preclinical biodistribution data on EGL-001, a novel anti-CTLA4-IL2 mutein fusion antibody designed to selectively deplete tumor-infiltrating regulatory T cells (Tregs).
Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and predicts that a treatment could be approved in the next 5-10 years.
Transmission electron microscopy (TEM) is well-known for performing in situ studies in the nanoscale. Hence, scientists took this opportunity to explore the subtle processes occurring in living ...
Engineered regulatory T cells were able to calm the gluten-reactive effector T cells that cause the autoimmune response seen in celiac disease.
RegCell is a global biotechnology company pioneering cell therapies for autoimmune diseases and transplantation. With newly established U.S. headquarters and deep roots in Japan's renowned scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results